On Monday, Merck & Co Inc (NYSE:MRK) and Moderna, Inc. (NASDAQ:MRNA) announced the initiation of INTerpath-009, a pivotal Phase 3 trial of V940 (mRNA-4157). V940 is an investigational ...

Merck (MRK) and Moderna (MRNA) announced the initiation of INTerpath-009, a pivotal Phase 3 randomized clinical trial evaluating V940, an investigational individualized neoantigen therapy ...

This article will explore 15 of the most iconic logos ever created. We'll examine what makes them memorable, their history, and their impact. Logos are an essential part of any brand's identity. An ...

Let's plug into the power of great branding design and explore ten electronics logos that have wired themselves into our collective consciousness. In a world drowning in noise, the whisper of a great ...

“Years later, this breakthrough would be the key to delivering Moderna’s mRNA vaccine into the targeted cells that would trigger an immune response in the body.” – Northwestern complaint ...

For instance, many wonder if they can change the boot logo in Windows 10. By default, every time you boot the OS, a Windows logo appears on the screen with a few dots spinning in a circle which ...

Blockchain is evolving from privacy-focused to transparent due to increased regulations and fraud incidents. Experts advocate for a balance between privacy and transparency using technologies like ...

A year after New York enacted its pay transparency law, experts say it's difficult to measure how effective it has been, even as jobseekers and employers support it. The state law requires ...

Jefferies analyst Michael Yee maintained a Hold rating on Moderna (MRNA – Research Report) today and set a price target of $55.00. The company’s shares closed yesterday at $57.46. Yee covers ...

Oct 16 (Reuters) - Moderna (MRNA.O), opens new tab was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused the company of misusing the ...

Despite giving the world one of the first and most widely used COVID-19 vaccines, shares of Moderna MRNA have lost significantly in the past couple of years due to declining sales amid low demand ...

The New Year’s Day deadline is fast approaching for companies formed before January 1, 2024, to report beneficial ownership information under the Corporate Transparency Act. Begin reviewing now ...